Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing

NIH RePORTER · NIH · R44 · $69,068 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10355813
Project number
3R44HL149566-02S1
Recipient
CURI BIO INC
Principal Investigator
Nicholas Andrew Geisse
Activity code
R44
Funding institute
NIH
Fiscal year
2021
Award amount
$69,068
Award type
3
Project period
2019-09-01 → 2022-05-31